AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jeong, Y. Y.
Right arrow Articles by Kamishima, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeong, Y. Y.
Right arrow Articles by Kamishima, T.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Small (<20 mm) Enhancing Hepatic Nodules Seen on Arterial Phase MR Imaging of the Cirrhotic Liver: Clinical Implications

Yong Yeon Jeong1,2, Donald G. Mitchell1 and Tamotsu Kamishima1,3

1 Department of Radiology, Thomas Jefferson University Hospital, 132 S. 10th St., 1096 Main Bldg., Philadelphia, PA 19107.
2 Present address: Department of Diagnostic Radiology, Chonnam National University Medical School, 8 Hackdong, Dongku, Kwangju, South Korea.
3 Present address: Department of Radiology, Hokkaido University School of Medicine, North-15, West-7, Kita-Ku, 0608638, Sapporo, Japan.



View larger version (134K):

[in a new window]
  		Fig. 1A. —Hepatocellular carcinoma with interval nodule growth in 41-year-old man. Nodule shows no change of signal intensity or enhancement homogeneity. Axial T1-weighted gradient-echo MR image (TR/TE, 130/4.2) shows nodule as isointense.

 


View larger version (155K):

[in a new window]
  		Fig. 1B. —Hepatocellular carcinoma with interval nodule growth in 41-year-old man. Nodule shows no change of signal intensity or enhancement homogeneity. Axial fast spin-echo MR image (TR/TEeff, 3157/80) reveals isointense nodule.

 


View larger version (128K):

[in a new window]
  		Fig. 1C. —Hepatocellular carcinoma with interval nodule growth in 41-year-old man. Nodule shows no change of signal intensity or enhancement homogeneity. Axial T2-weighted gadolinium-enhanced gradient-echo dynamic MR image (TR/TE, 130/1.5) obtained during arterial phase of bolus reveals early homogenous enhancement (arrow) of 13-mm nodule.

 


View larger version (117K):

[in a new window]
  		Fig. 1D. —Hepatocellular carcinoma with interval nodule growth in 41-year-old man. Nodule shows no change of signal intensity or enhancement homogeneity. On follow-up axial T1-weighted gradient-echo image (120/4.2) obtained 3 months later at the same level as C, nodule is isointense.

 


View larger version (150K):

[in a new window]
  		Fig. 1E. —Hepatocellular carcinoma with interval nodule growth in 41-year-old man. Nodule shows no change of signal intensity or enhancement homogeneity. Axial T2-weighted fast spin-echo MR image (TR/TEeff, 7500/100) obtained at same time as D shows nodule as isointense.

 


View larger version (111K):

[in a new window]
  		Fig. 1F. —Hepatocellular carcinoma with interval nodule growth in 41-year-old man. Nodule shows no change of signal intensity or enhancement homogeneity. Axial T1-weighted gadolinium-enhanced gradient-echo MR image (TR/TE, 120/2.1) obtained at same time as D shows considerable growth of nodule (arrow), now measuring 21 mm.

 


View larger version (125K):

[in a new window]
  		Fig. 2A. —42-year-old woman with hepatocellular carcinoma. Nodule shows interval growth and change of enhancement homogeneity. Axial T1-weighted gradient-echo image (TR/TE, 130/2.2) shows nodule as isointense.

 


View larger version (127K):

[in a new window]
  		Fig. 2B. —42-year-old woman with hepatocellular carcinoma. Nodule shows interval growth and change of enhancement homogeneity. Axial T2-weighted fast spin-echo image (TR/TEeff, 5000/100) shows nodule as isointense.

 


View larger version (114K):

[in a new window]
  		Fig. 2C. —42-year-old woman with hepatocellular carcinoma. Nodule shows interval growth and change of enhancement homogeneity. Axial gadolinium-enhanced gradient-echo dynamic MR image (TR/TE, 7/2) obtained during arterial phase of bolus reveals 6-mm nodule (arrow) with homogeneous enhancement.

 


View larger version (127K):

[in a new window]
  		Fig. 2D. —42-year-old woman with hepatocellular carcinoma. Nodule shows interval growth and change of enhancement homogeneity. Follow-up axial T1-weighted gradient-echo MR image (TR/TE, 130/2.2) obtained 15 months later at same level as C shows nodule (arrow) is hypointense and now has grown to 15 mm.

 


View larger version (128K):

[in a new window]
  		Fig. 2E. —42-year-old woman with hepatocellular carcinoma. Nodule shows interval growth and change of enhancement homogeneity. Axial T2-weighted fast spin-echo MR image (TR/TEeff, 4000/90) obtained at same time as D shows nodule (arrow) as more intense than liver.

 


View larger version (110K):

[in a new window]
  		Fig. 2F. —42-year-old woman with hepatocellular carcinoma. Nodule shows interval growth and change of enhancement homogeneity. Axial T1-weighted gadolinium-enhanced gradient-echo MR image (TR/TE, 7/2) obtained at same time as D shows inhomogenous enhancement (arrow) of nodule.

 


View larger version (117K):

[in a new window]
  		Fig. 3A. —Benign lesion in 63-year-old man that was not seen on follow-up images. On axial T1-weighted gradient-echo MR image (TR/TE, 120/4.2), nodule is not visible.

 


View larger version (109K):

[in a new window]
  		Fig. 3B. —Benign lesion in 63-year-old man that was not seen on follow-up images. On axial T2-weighted fast spin-echo MR image (TR/TEeff, 4000/96), nodule is not visible.

 


View larger version (140K):

[in a new window]
  		Fig. 3C. —Benign lesion in 63-year-old man that was not seen on follow-up images. Axial gadolinium-enhanced gradient-echo dynamic MR image (TR/TE, 120/2.2) obtained during arterial phase of bolus shows 8-mm nodule (arrow) with homogeneous enhancement.

 


View larger version (110K):

[in a new window]
  		Fig. 3D. —Benign lesion in 63-year-old man that was not seen on follow-up images. On follow-up axial T1-weighted gradient-echo image (150/4.2) obtained 28 months later, nodule is not visible.

 


View larger version (107K):

[in a new window]
  		Fig. 3E. —Benign lesion in 63-year-old man that was not seen on follow-up images. On axial T2-weighted single-shot fast spin-echo MR image (infinite/100) obtained at same time as D, nodule is not visible.

 


View larger version (131K):

[in a new window]
  		Fig. 3F. —Benign lesion in 63-year-old man that was not seen on follow-up images. On axial gadolinium-enhanced gradient-echo dynamic MR image (7/2) of left hepatic lobe obtained at same time as D, nodule is not visible.

 


View larger version (13K):

[in a new window]
  		Fig. 4. —Graph shows tumor-doubling time (longitudinal axis) in seven hepatocellular carcinomas with interval growth versus difference of tumor diameter in millimeters (transverse axis). Mean doubling time was 2.47 ± 1.25 months and was less than 5 months in all tumors.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Roentgen Ray Society.